Literature DB >> 2079965

Homologous recombination is elevated in some Werner-like syndromes but not during normal in vitro or in vivo senescence of mammalian cells.

R Z Cheng1, S Murano, B Kurz, R J Shmookler Reis.   

Abstract

Werner syndrome (WS) is a recessive genetic condition associated with markedly reduced replicative lifespans of cells in culture, high chromosomal instability in vivo and in vitro, and premature appearance of many characteristics of normal aging, including an increased incidence of cancer. We have monitored plasmid homologous recombination frequencies in diploid fibroblasts from 6 Werner or Werner-like syndrome patients, following transfection with a plasmid substrate containing 2 overlapping fragments of the TN5 Neor gene. Plasmid DNA recovered from these cells was then assayed for homologous recombination by (a) transformation of recA- bacteria to Ampr (indicating total viable plasmid) or Neor (indicating viable recombinant plasmid), and (b) by limited-cycle polymerase chain reaction (PCR) to co-amplify a recombinant fragment containing the overlap region, and a control region of the same plasmid, without bacterial transformation. Bacterial assay data indicated that recombination rates in 3 of the 6 WS strains were significantly elevated above normal controls; 4 of 6 appeared elevated by PCR assay. The highest-recombination WS strain showed evidence of reduced degradation of transfected plasmid DNA. For this small sample of WS strains, clinical severity of WS was not well correlated with recombination rate as determined by either assay (Pearson r = 0.78, not significant, for PCR assay); elevated recombination may, however, define a subset of WS at greatest risk for cancer and/or atherosclerosis. PCR assay of a hyperoxia-resistant HeLa cell line, displaying substantially increased chromosome breakage, indicated increased recombination between direct-repeat fragments. Nevertheless, elevated recombination in WS strains is unlikely to be secondary to impaired replicative capacity characteristic of WS cells, or to defective repair of chromosome damage which is increased in WS, since recombination in non-WS strains was unaffected by passage level or repeated UV irradiation.

Entities:  

Mesh:

Year:  1990        PMID: 2079965     DOI: 10.1016/0921-8734(90)90008-f

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  Partial suppression of the fission yeast rqh1(-) phenotype by expression of a bacterial Holliday junction resolvase.

Authors:  C L Doe; J Dixon; F Osman; M C Whitby
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.

Authors:  R M Brosh; J K Karow; E J White; N D Shaw; I D Hickson; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

3.  The premature ageing syndrome protein, WRN, is a 3'-->5' exonuclease.

Authors:  S Huang; B Li; M D Gray; J Oshima; I S Mian; J Campisi
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

4.  Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group.

Authors:  C E Yu; J Oshima; E M Wijsman; J Nakura; T Miki; C Piussan; S Matthews; Y H Fu; J Mulligan; G M Martin; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 5.  Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.

Authors:  Venkateswarlu Popuri; Takashi Tadokoro; Deborah L Croteau; Vilhelm A Bohr
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-29       Impact factor: 8.250

6.  Characterization of the human and mouse WRN 3'-->5' exonuclease.

Authors:  S Huang; S Beresten; B Li; J Oshima; N A Ellis; J Campisi
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

Review 7.  Potential for pharmacological intervention in Werner syndrome.

Authors:  S Murano
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

8.  Functional interaction between the Werner Syndrome protein and DNA polymerase delta.

Authors:  A S Kamath-Loeb; E Johansson; P M Burgers; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  Depletion of Werner helicase results in mitotic hyperrecombination and pleiotropic homologous and nonhomologous recombination phenotypes.

Authors:  Jennifer J Rahn; Megan P Lowery; Luis Della-Coletta; Gerald M Adair; Rodney S Nairn
Journal:  Mech Ageing Dev       Date:  2010-08-12       Impact factor: 5.432

10.  Recombination and its roles in DNA repair, cellular immortalization and cancer.

Authors:  M A Shammas; R J Shmookler Reis
Journal:  Age (Omaha)       Date:  1999-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.